Black Diamond Therapeutics
BDTX
BDTX
73 hedge funds and large institutions have $107M invested in Black Diamond Therapeutics in 2023 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 23 increasing their positions, 15 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
41.34% less ownership
Funds ownership: 113.45% → 72.11% (-41%)
49% less capital invested
Capital invested by funds: $209M → $107M (-$102M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
73
Holding in Top 10
–
Calls
$1.05M
Puts
$109K
Top Buyers
| 1 | +$6.18M | |
| 2 | +$3.69M | |
| 3 | +$1.38M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.15M |
| 5 |
Barclays
London,
United Kingdom
|
+$568K |
Top Sellers
| 1 | -$8.59M | |
| 2 | -$4.33M | |
| 3 | -$3.79M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.43M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.84M |